Millie Nelson

Millie Nelson

Editor, BioXconomy

Latest from Millie Nelson

thumbnail
Investment
What’s your secret sauce? VC’s on what makes a compelling pitchVC’s on what makes a compelling pitch
byMillie Nelson
Oct 24, 2024
3 Min Read
Eli Lilly logo
Innovation
From east to west: Lilly plans incubators in China and UKFrom east to west: Lilly plans incubators in China and UK
byMillie Nelson, Richard Daverman
Oct 18, 2024
2 Min Read

All from Millie Nelson

Dollar notes
Investment
The rise of radiopharmaceuticals sees big pharma back Aktis’ $175m Series B
The rise of radiopharmaceuticals sees big pharma back Aktis’ $175m Series B
Oct 17, 2024
|
2 Min Read
byMillie Nelson
Business Strategy
Build trust by making healthcare fairer and more equitable, say experts
Build trust by making healthcare fairer and more equitable, say experts
Oct 14, 2024
|
3 Min Read
byMillie Nelson
Green leaf with sustainability symbol
Business Strategy
The sustainability series: Reflect, rethink, and reform
The sustainability series: Reflect, rethink, and reform
Oct 11, 2024
|
14 Min Read
byMillie Nelson
Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Oct 1, 2024
|
2 Min Read
byMillie Nelson
Overhead view of business people working and funding
Investment
$325 million Series C funding in its Arsenal (Biosciences)
$325 million Series C funding in its Arsenal (Biosciences)
Sep 25, 2024
|
1 Min Read
byMillie Nelson
Wooden block with people icons
Partnering
Want to be a partner of choice? Distinguish yourself in the space
Want to be a partner of choice? Distinguish yourself in the space
Sep 25, 2024
|
4 Min Read
byMillie Nelson
Partnering
To be truly great you need to partner, says J&J
To be truly great you need to partner, says J&J
Sep 25, 2024
|
7 Min Read
byMillie Nelson
Christmas present
Partnering
RayzeBio: A Christmas to remember
RayzeBio: A Christmas to remember
Sep 25, 2024
|
3 Min Read
byMillie Nelson
People making business deals
Partnering
Prometheus and Merck: Under the bonnet of the largest pre-Phase III M&A deal
Under the bonnet of the largest pre-Phase III M&A deal
Sep 25, 2024
|
6 Min Read
byMillie Nelson
Oncology
Partnering
Bayer and NextRNA: One partnership, two oncology programs
Bayer and NextRNA: One partnership, two oncology programs
Sep 25, 2024
|
3 Min Read
byMillie Nelson
Abu Dhabi Global Healthcare Week 2024
Partnering
BioNTech: Partnerships are key to deliver drugs at scale
BioNTech: Partnerships are key to deliver drugs at scale
May 20, 2024
|
2 Min Read
byMillie Nelson
Abu Dhabi Global Healthcare Week
Innovation
From healthcare to health: 'No country can do this alone,' say experts in UAE
'No country can do this alone,' say experts in UAE
May 14, 2024
|
2 Min Read
byMillie Nelson
Business Strategy
Building successful teams in biotech: “The future is female and very colorful”
Building successful teams in biotech
May 7, 2024
|
2 Min Read
byMillie Nelson
Wedding rings
Partnering
Perfect match: Picking your CDMO is like a marriage, says Bayer
Picking your CDMO is like a marriage, says Bayer
Apr 11, 2024
|
2 Min Read
byMillie Nelson
BIO-Europe Spring
Partnering
Competitor today, friend tomorrow: Why partnering is critical for biopharma success
Why partnering is critical for biopharma success
Apr 5, 2024
|
4 Min Read
byMillie Nelson
Mounajro
Innovation
GLP-1 boom causing pharma players FOMO
GLP-1 boom causing pharma players FOMO
Mar 25, 2024
|
2 Min Read
byMillie Nelson
CEO of Poseida, Kristin Yarema
Business Strategy
Poseida: New CEO, same passion for allogeneic therapies
Poseida: New CEO, same passion for allogeneic therapies
Feb 26, 2024
|
7 Min Read
byMillie Nelson
Innovation
GSK, Novartis, Calliditas among winners at LSX Awards
GSK, Novartis, Calliditas among winners at LSX Awards
Nov 16, 2023
|
3 Min Read
byMillie Nelson
Dirk Lange
Business Strategy
Testing times: MilliporeSigma talks CDMO competition
Testing times: MilliporeSigma talks CDMO competition
Oct 11, 2023
|
3 Min Read
byMillie Nelson
Broken heart
Partnering
It’s not me, it’s you! Experts on when you should dump your CDMO
Experts on when you should dump your CDMO
Sep 22, 2023
|
1 Min Read
byMillie Nelson
Note with politics written on it
Business Strategy
Patient access is political, say CGT experts
Patient access is political, say CGT experts
Jan 9, 2023
|
2 Min Read
byMillie Nelson
Nov 18, 2024
Championing life sciences innovators with the ultimate Biotech, Healthtech and Medtech Networking & Pitching Event. With 8 incredible presenting stages for startup, growth stage and publicly listed Biotech, Healthtech, Medtech, TechBio, Digital Health and Deeptech companies.
Register

News from APAC

thumbnail
Hubs
Eyes on Asia: News from Sanofi, Bayer, AZ plus the return of VC?News from Sanofi, Bayer, AZ plus the return of VC?
byRichard Daverman
Sep 29, 2024
2 Min Read
Chinese flag — Photo
Investment
China biopharma faces a pause; how bad is it?China biopharma mid-2023 market summary
byRichard Daverman
Sep 21, 2024
4 Min Read
thumbnail
Investment
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and moreEyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more
byRichard Daverman
Sep 18, 2024
4 Min Read

Recommended

Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
three member panel on stage
Innovation
‘Data matters most’ in biotech, and AI is here to help
‘Data matters most’ in biotech, and AI is here to help
Oct 23 - Dec 31, 2025
partneringONE’s first-in-class partnering technology powers global events and enhances your networking experience.
LEARN MORE
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated